A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Category | Primary Site | Code? |
|---|---|---|---|
| Molybdenum | Ancillary Agent | No | |
| Trestolone Acetate | Hormones and hormonal mechanisms | No | |
| Famciclovir | AIDS drug | No | |
| Fluorothymidine | AIDS drug | No | |
| MSL-109 | AIDS drug | No | |
| Fansidar | Ancillary Agent, AIDS drug | No | |
| Trospectomycin Sulfate | AIDS drug | No | |
| N1177 | Ancillary Agent | Other cancer | No |
| Methadone Hydrochloride | Ancillary Agent | No | |
| Nalaxone Hydrochloride | Ancillary Agent | No | |
| Flurbiprofen | Ancillary Agent | No | |
| Mucopirocin | AIDS drug | No | |
| Ryoncil | Other therapy | No | |
| Morphine Sulfate | Ancillary Agent | No | |
| U-87201E | AIDS drug | No | |
| Etretinate | Differentiation inducing agent | No | |
| U-85961 | AIDS drug | No | |
| EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) | Ancillary Agent | No | |
| Erythropoietin | Ancillary Agent | AIDS, Opportunistic infection | No |
| Plerixafor | Ancillary Agent | MM, Multiple myeloma, NHL, Non-hodgkins Lymphoma | No |
| Urokinase | Ancillary Agent | No | |
| Naltrexone Hydrochloride | Ancillary Agent | No | |
| Mycophenolate Mofetil | Ancillary Agent | No | |
| Myristic acid analogs | AIDS drug | No | |
| Mupirocin | Ancillary Agent | AIDS, Opportunistic infection | No |
| Ethambutol Hydrochloride | AIDS drug | No | |
| Ethacrynic Acid | Ancillary Agent | No | |
| MPI5020 | Ancillary Agent | Breast cancer | No |
| Triflupromazine Hydrochloride | Ancillary Agent | No | |
| Proscar | Hormones and hormonal mechanisms | Prostate | No |
| Trimethoprim | Ancillary Agent, AIDS drug | AIDS, Opportunistic infection | No |
| Trimethobenzamide Hydrochloride | Ancillary Agent | No | |
| Etidronate Disodium | Ancillary Agent | No | |
| Etoprine | Ancillary Agent | No | |
| Trichosanthin | AIDS drug | No | |
| Metoclopramide | Ancillary Agent | No | |
| Endorphin | Ancillary Agent | No | |
| Midazolam Hydrochloride | Ancillary Agent | No | |
| Epoetin Alfa | AIDS drug, Ancillary Agent | No | |
| Methylphenidate Hydrochloride | Ancillary Agent | No | |
| Tropisetron | Ancillary Agent | No | |
| Mirostepin | Ancillary Agent | Breast cancer | No |
| Misonidazole | Ancillary Agent | No | |
| Ethionamide | AIDS drug | No | |
| Naproxen Sodium | Ancillary Agent | No | |
| N-acetylcysteine | AIDS drug | No | |
| U-90152 | AIDS drug | No | |
| Nabilone | Ancillary Agent | No | |
| Mycophenolic acid | Ancillary Agent | No | |
| MN rgp120/HIV-1 | AIDS drug | No |
| Name | Primary Site |
|---|---|
| CGI | |
| CHAMOCA | |
| CHD | |
| CHD-R | |
| CHF | |
| CHOB | |
| CHOP | |
| CIA | |
| CIM | |
| CLAG | |
| CLAG-M | |
| CMC-VAP | |
| CMF-FLU | |
| CMFH | |
| CMFP-VA | |
| CMFPT | |
| CMFPTH | |
| CMFT | |
| CMFVAT | |
| CMOPP | |
| CNOP | |
| CODOX | |
| COMB | Lung, Head and Neck, Melanoma |
| COMET-A | |
| COMLA | |
| COPADM | |
| COPP | |
| CPR | |
| CRd | |
| CTCb | |
| CTD | |
| CTX-Plat | |
| CVA-BMP | |
| CVAD | |
| CVB | |
| CVBD | |
| CVDD | |
| CVEB | |
| CVI | |
| CVP-BLEO | |
| CYCLONE | |
| CYVE | |
| CarbF | |
| ChlVPP | |
| CyBor-D | |
| CyVADIC | |
| Cyta BOM | |
| CytaBOM | |
| D-PACE | |
| DAP |
Home